Wilkinson, D., Ramjee, G., Tholandi, M., Rutherford, G.
Trials show that nonoxynol-9 does not reduce the risk of women acquiring HIV infection from men, and its use is associated with a higher risk of genital lesions in women. Given the risk of harm to women, it is argued that no further trials of N-9 as prophylaxis against HIV are warranted.
This Evidence Update was adapted from Wilkinson D, Ramjee G, Tholandi M, Rutherford G. Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men (Cochrane Review). In: The Cochrane Library, Issue 3, 2004.
Evidence Update, HIV/AIDS Series Effective Healthcare Alliance Programme, Liverpool School of Tropical Medicine 2pp.